|
nome  clicca sulle marchi per confrontare i prezzi |
» Comperiamo locale, etica e al migliore prezzo su Ethishop  |
|
|
|
Azionista
Attività e quota di mercato
Stabilimenti e produzione
anno | delinquenza finanziaria | | | attivo | | fonte |
2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. tradurre |
| | | |   | | Canadian Press |
1998 |
| | | 7,1 |   | miliardi US$ | Forbes |
|
anno | delinquenza finanziaria | fatturato | profitti | attivo | riscatto | fonte |
|
|
|